Bank7 (BSVN) Form 144 Filed for 13,084-Share Sale via Stifel Nicolaus

Rhea-AI Filing Summary

Form 144 notice for Bank7 Corp. (BSVN) records a proposed sale of 13,084 shares of common stock through Stifel Nicolaus & Company Inc. with an aggregate market value of $645,782.00. The filing lists 9,450,979 shares outstanding for the issuer and an approximate sale date of 08/26/2025 on the Nasdaq. The shares were acquired as Restricted Stock Units from the issuer on 09/21/2021, with 65,500 units originally acquired and payment noted as cash on the acquisition date. The filer reports no securities sold in the past three months and includes the standard attestation that no undisclosed material adverse information is known.

Insights

Securities Analyst

TL;DR: Insider plans to sell 13,084 restricted-stock-derived shares worth $645,782; filing is routine and provides limited market-moving information.

The Form 144 documents a proposed sale through a broker (Stifel Nicolaus) and identifies the holdings as originally received as restricted stock units from the issuer on 09/21/2021. The filing confirms the transaction will be executed on Nasdaq and reports no related sales in the prior three months. For investors, this is a standard insider sale notice and, standing alone, does not disclose material operational or financial changes at the company.

Corporate Governance Expert

TL;DR: Routine compliance disclosure of an insider sale; no allegations or governance concerns are stated in the filing.

The notice contains required representations about absence of undisclosed material information and documents the origin of the securities as restricted stock units granted by the issuer. The filing includes broker details and the intended sale date but does not provide any trading plan adoption date or additional context. From a governance perspective, this is a standard disclosure satisfying Rule 144 requirements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	13084	645782.00	9450979	08/26/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/21/2021	Restrictied Stock Units	Issuer			65500	09/21/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Bank7 Corp. (BSVN) disclose?

The form discloses a proposed sale of 13,084 shares valued at $645,782.00, to be executed on 08/26/2025 on Nasdaq through Stifel Nicolaus & Company Inc.

How were the shares acquired that are being sold in the BSVN Form 144?

The shares originated from Restricted Stock Units granted by the issuer on 09/21/2021; the filing shows 65,500 units were acquired on that date.

Does the filing report any securities sold in the past three months for the seller?

No. The Form 144 indicates "Nothing to Report" for securities sold during the past three months.

Who is the broker named in the Bank7 Corp. Form 144?

Stifel Nicolaus & Company Inc., 501 N Broadway, St. Louis, MO 63102, is listed as the broker for the proposed sale.

What representations does the filer make in the Form 144?

The filer attests they do not know any material adverse information about the issuer that has not been publicly disclosed.